Advancing brain health, together.
Five invitation-only summits at one Berkshires estate. Forty scientists, clinicians, founders, and investors gather for candid conversation, time in nature, and practical collaboration.
All conversations are off the record.
Neurotechnology Summit · November 5–8, 2026 · The Thyme
Presented by Dragonfly 44 Capital, GFI Partners, and Cooley.
Invitations are being extended. Partnership and sponsorship opportunities remain.
Bringing the right people together.
Researchers, clinicians, founders, and funders rarely have enough time together. Patient advocates and other leaders bring perspectives that connect research to the realities of care.
The Berkshires Brain Summit creates space for candid conversation and practical collaboration, helping turn science into better care.
40 invited participants
Each participant is invited or nominated, bringing a relevant perspective to the summit.
Off the record
Sessions follow Chatham House-style norms, with no recording or attribution.
Built for collaboration
Conversations create opportunities for collaborations, pilots, funding, and hires.
- NeurotechnologyThe instruments of measuring and modulating the nervous system.November 5–8, 2026
- Psychedelics and PsychoplastogensThe science and translation of lasting neural change.February 18–21, 2027
- NeurodegenerationFrom lab to clinic in the diseases of the aging brain.April 22–25, 2027
- NeuroAIWhere neuroscience meets machine intelligence.June 10–13, 2027
- AutismResearch, care, and lived experience.Date shared
40 participants at each summit. Conversations off the record.
"Berkshires Brain Summit was not to be missed. The format and environment leads to building deep and honest relationships with the other incredible leaders in attendance. We came away with game changing business opportunities and new perspectives. Highly recommend!"
"I left with much more than I expected. Meaningful connections. New professional opportunities. … I left a better professional and, I think, a better person."